Navigation Links
Abnormal EKG can predict death in stroke patients
Date:3/19/2009

People who suffer an ischemic stroke and also have an abnormality in the heart's electrical cycle are at a higher risk of death within 90 days than people who do not have abnormal electrical activity at the time of emergency treatment, according to new research.

The study also provides a threshold at which the threat of death is highest: QTc intervals greater than 440 milliseconds in women and 438 milliseconds in men have the worst prognosis. The findings are published online March 20, 2009, in the Journal of Stroke and Cerebrovascular Diseases.

"From a clinical perspective, our study offers additional parameters to consider while treating stroke patients in the Emergency Department setting,' said corresponding author Latha G. Stead, M.D., professor and chair of the Department of Emergency Medicine at the University of Rochester Medical Center, who recently joined the URMC from the Mayo Clinic. "It appears that reviewing the medications a patient is taking and looking specifically for those that might prolong the QTc interval would be a useful practice."

The QTc interval is a measure of the electrical activity of the heart. An EKG records the waves of activity and its pattern, which is labeled with letters Q and T. Doctors look for the appropriate intervals between each letter, showing that the heart's electrical signals are steadily passing through the ventricles. A prolonged QTc interval means it takes too long for the electrical signal to pass.

Prolonged QTc intervals can be the result of a rare genetic disorder, medications, electrolyte imbalances, or congenital heart disease. Scientific data on the relationship between abnormal QTc intervals and death has been inconsistent, and few studies have looked at this relationship in the context of acute ischemic stroke, Stead said.

Researchers studied the medical records of 345 ischemic stroke patients at the Mayo Clinic, treated between 2001 and 2004, and followed for 90 days. Further analysis was done to see if the researchers could identify a QTc cutoff that would accurately predict death within 90 days.

About 35 percent of the patients had a prolonged QTc interval at the time of the emergency department visit. An estimated 81 percent of all patients were expected to survive the next three months. However, results showed that only 70.5 percent of the patients with a prolonged QTc interval survived compared with 87.1percent of the patients without a prolonged QTc interval.

In addition, researchers found that although the causes of death ranged from stroke to cardiac illnesses to cancer and respiratory failure, most patients died of stroke or cardiac causes. In those cases, about half of the patients had prolonged QTc intervals. Among the stroke survivors, patients with prolonged QT intervals had poorer functional outcomes.

About 795,000 Americans each year suffer a new or recurrent stroke. That means, on average, a stroke occurs every 40 seconds, according to the American Stroke Association. Ischemic strokes, obstructions of the blood vessels supplying blood to the brain, account for the majority of cases.

Stead is supported by the Mayo Foundation Emergency Medicine Career Research Career Development Award.


'/>"/>

Contact: Leslie Orr
Leslie_Orr@urmc.rochester.edu
585-275-5774
University of Rochester Medical Center
Source:Eurekalert

Related medicine news :

1. Brain abnormality found in boys with attention deficit hyperactivity disorder
2. Abnormal Heart Rhythm Boosts Death Risk for Diabetics
3. Risk Score May Predict Abnormal Heart Rhythm
4. New Drug Shows Promise Against Heartbeat Abnormality
5. Rhythm abnormality of unknown origin strongly predicts sudden death risk in heart disease patients
6. Abnormal Heart Function Reduces Exercise Capacity
7. Gene abnormality found to predict childhood leukemia relapse
8. Decreased activity of basal ganglia is the main cause of abnormal muscle constrictions in dystonia
9. Molecular Breast Imaging Performs Better Than Ultrasound in Patients With Mammographic Abnormalities
10. Novel imaging technique reveals brain abnormalities that may play key role in ADHD
11. Scans Reveal Brain Abnormalities in Fibromyalgia Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... 22, 2017 , ... The VA Maryland Health Care System ... awarded the Baltimore VA Medical Center, a division of the VA Maryland Health ... to promote waste reduction and promote recycling. Also, Practice Greenhealth has recognized ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... health science curriculum , is pleased to announce a new online course entitled ... online course provides practical insights and evidence-based strategies for achieving optimal well-being and ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... that the introduction of school choice can promote economic development in economically distressed ... that has, according to the report, contributed to the economic development of the ...
(Date:6/20/2017)... ... 2017 , ... Leading dental clinicians, Drs. Ashlyn Price, Autumn Mayers and Ron ... Anatomage systems. With advanced digital images and modeling capabilities, the dentists identify all of ... restore oral health for those who are missing teeth in Midlothian, VA. ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... years ago today, the Monterey Pop Festival opened its gates ... Francisco "Summer of Love."  To celebrate the anniversary, Northern Light® ... market research portals that it will begin delivering to customers ... "Summer of Love (For Our Customers)."  ... Northern Light ...
(Date:6/14/2017)... WINSTON-SALEM, N.C. , June 14, 2017  In ... the Creative Startups pitch competition and came ... virtual reality platform is described by Forbes as "entering ... the American Medical Association as teaching "empathy to medical ... success, the startup was recently named a finalist for ...
(Date:6/11/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... studies of galcanezumab, an investigational treatment for the prevention ... several key secondary endpoints for galcanezumab compared to placebo ... (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today at ... Boston . "The ...
Breaking Medicine Technology: